Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nicotine patch

This article was originally published in The Tan Sheet

Executive Summary

Transdermal patch bolsters effectiveness of Rx Tourette's drug haloperidol in relieving "severity and frequency of motor tics," USF researchers report in September issue of Journal of Clinical Psychiatry. Conducted July 1994-1998, randomized, double-blind, placebo-controlled study explored effects of daily 7 mg nicotine patch use as adjuvant to haloperidol therapy in patients aged 8-18. Although no evidence of addiction was found, nicotine group reported significantly more nausea, dizziness. Researchers plan to "search for artificial compounds that would mimic the effects of [nicotine] without its addictive risks or unwanted side effects"
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS093088

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel